NORML New Zealand: working for marijuana law reform adverts - click for details of how to advertiseDrug Testing Fails - Oppose Drug Testing in Schools   
   Welcome guest, you can login or register
 
  
   Home  ::  MyNORML  ::  Topics  ::  Submit News  ::  Resources  ::  Links  ::  FAQ  ::  Forums  ::  Top 10
     NORML News
Spring 2009:
NORML News Spring 2009, on sale now!
get it here

     Social Networking
Bookmark and Share

     About NORML
· Join NORML
· Contact Us
· Donations
· NORML News Online
· NORML News Mag
· Old site

     Main Menu
· About NORML
· About Marijuana
· Medical Marijuana
· Hemp
· Laws
· Your Rights
· Get Active
· Events
· Politics

     Categories Menu
· All Categories
· archive
· Cannabis Inquiry '03
· Cannabis Inquiry '98
· Cannabis Research
· Drug Testing
· International News
· NORML News
· NORML Press Releases
· NZ Drug Education
· NZ Elections
· NZ Hemp
· Pot Culture
· Sativex
· Worldwide Weed

     Site Tools
· Home
· AvantGo
· Content
· FAQ
· Feedback
· Forums
· MP
· MyNORML
· Newshawk
· Parliamentary Questions
· Private Messages
· Recommend Us
· Resources
· Search
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links

     Who's Online
There are currently, 63 guest(s) and 0 member(s) that are online.

You are an Anonymous user. You can register for free.

CLASS A CONTROLLED DRUGS

Misuse of Drugs Act Schedule 1. Source: www.legislation.govt.nz

1.The following substances, namely:


• ACETORPHINE (03-acetyl-7,8-dihydro-7 a -[1 (R)-hydroxy-1-methyl-butyl]-06-methyl-6,14-endo ethenomorphine).

• • BUFOTENINE (3-(2-dimethylaminoethyl)-5-hydroxyindole).

• CANTHARIDIN (hexahydro-3a,7a-dimethyl-4,7-epoxyisobenzofuran-1,3-dione).

• COCAINE (methyl ester of benzoylecgonine), except when contained in a Class C controlled drug:**]

• DESOMORPHINE (dihydrodeoxymorphine).

• DET (N, N-diethyltryptamine).

• • DMA (2-amino-1-(2,5-dimethoxyphenyl) propane).]

• DMHP (3-(1,2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6 H-dibenzo[b, d] pyran).

• DMT (N, N-dimethyltryptamine).

• DOB (2-amino-1-(4-bromo-2, 5-dimethoxyphenyl) propane) (also known as bromo-DMA).]

• ETORPHINE (7,8-dihydro-7 a -[1 (R)-hydroxy-1-methylbutyl]-06-methyl-6,14-endo ethenomorphine).

• HEROIN (diacetylmorphine).

• KETOBEMIDONE (4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine).

• LYSERGIC ACID (essential precursor for manufacture of LSD).]

• LYSERGIDE (N, N-diethyllysergamide or lysergic acid diethylamide).

• MDA (2-amino-1-(3,4-methylenedioxyphenyl) propane).

• MESCALINE (3,4,5-trimethoxyphenethylamine).

• METHAMPHETAMINE (2-methylamino-1-phenylpropane).]

• • 5-METHOXYDIMETHYLTRYPTAMINE (5-methoxy-N, N-dimethyl-tryptamine).

• 2-METHOXY-4, 5-METHYLENEDIOXYAMPHETAMINE (2-amino-1-(2-methoxy-4, 5-methylenedioxyphenyl) propane) (also known as MMDA or MMDA-2).]

• 3-METHOXY-4, 5-METHYLENEDIOXYAMPHETAMINE (2-amino-1-(3-methoxy-4, 5-methylenedioxyphenyl) propane) (also known as MMDA).]

• MPTP (1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine).**]

• PARAHEXYL (3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b, d] pyran).

• PCE (N-ethyl-1-phenylcyclohexylamine).]

• PCPY 1-(1-phenylcyclohexyl) pyrrolidine).***

• PHP 1-(1-phenylcyclohexyl) pyrrolidine).***

• PEPTP (1-(2-phenylethyl)-4-phenyl-1,2,5,6-tetrahydropyridine).**]

• PHENCYCLIDINE (1-(1-phenylcyclohexyl) piperidine).

• PIPERIDYL BENZILATES (N-methylpiperidyl benzilates and N-ethylpiperidyl benzilates but excluding the methobromide salts).

• PMA (2-amino-1-(4-methoxyphenyl) propane).]

• PSILOCINE (3-(2-dimethylaminoethyl)-4-hydroxyindole).

• PSILOTSIN (3-(2-dimethylaminoethyl)-4-hydroxyindole).

• PSILOCYBINE (3-(2-dimethylaminoethyl) indol-4-yl dihydrogen phosphate).

• STP,DOM (2-amino-1-(2,5-dimethoxy-4-methyl) phenylpropane).

• TCP (1-[1-(2-thienyl) cyclohexyl] piperidine).***]

• • THALIDOMIDE (a -phthalimidoglutarimide).

• TMA (2-amino-1-(3, 4, 5-trimethoxyphenyl) propane).]

2.The isomers of the substances mentioned in this Schedule whenever the existence of such isomers is possible within the specific chemical designation.

3.The esters and ethers of the substances mentioned in this Schedule and the esters and ethers of the isomers mentioned in clause 2 of this Schedule whenever the existence of such esters or ethers is possible.

4.The salts of the substances mentioned in this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Schedule.

5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Schedule.


Provided for advisory purposes only - some amendments may have been made subsequent to this. See www.legislation.govt.nz for the most up-to-date version of the Misuse of Drugs Act.








Unless stated otherwise, copyright © 1998-2005 by NORML New Zealand: working for marijuana law reform

Published on: 2006-03-23 (7514 reads)

[ Go Back ]

Home  ::  About NORML  ::  About Marijuana  ::  Hemp  ::  Medical Marijuana  ::  Your Rights  ::  Laws  ::  Get Active  ::  Politics

Bookmark and Share

National Organisation for the Reform of Marijuana Laws, New Zealand (NORML New Zealand Inc)
PO Box 3307, Auckland, New Zealand

(c) 1998-2009 All rights reserved by NORML New Zealand Inc. except all comments and forum posts which are property of their authors.

Powered by PHP-Nuke